IL6 and juvenile idiopathic arthritis: Prospectively collected bio samples from patients with CNO/CRMO, various forms of JIA, and other inflammatory differential diagnoses together with detailed information on clinical activity will allow further evaluation of the applicability of serum IL-6 as discriminator between CRMO and differential diagnoses.